Investigation of isomer formation upon coordination of bifunctional histidine analogues with 99mTc/Re(CO)3.

Histidine is a convenient tridentate chelator used in the synthesis of technetium-99m radiopharmaceuticals, as it can be pendantly attached to a biomolecule for molecular imaging applications. Once coordinated, it forms a neutral complex that is capable of forming diastereomers at the alpha amine of the histidine. This is demonstrated through the synthesis and characterization of four different histidine chelators; three small molecule chelators, which consist of a benzylated histidine at the alpha amine, and one modified dipeptide, containing a phenylalanine derivative at the C-terminus and a histidine at the N-terminus. Upon rhenium coordination, two products are observed, each having the desired exact mass of the metal-containing species. The two products have been characterized through LC-MS, (1)H, gCOSY, NOESY and ROESY NMR experiments, and the relative stereochemistry determined. The implications of diastereomer formation when using this chelation system for creating molecular imaging agents is also discussed.

[1]  Shuang Liu,et al.  99mTc-centered one-pot synthesis for preparation of 99mTc radiotracers. , 2011, Dalton transactions.

[2]  L. Marzilli,et al.  Several novel N-donor tridentate ligands formed in chemical studies of new fac-Re(CO)3 complexes relevant to fac-99mTc(CO)3 radiopharmaceuticals: attack of a terminal amine on coordinated acetonitrile. , 2010, Inorganic chemistry.

[3]  L. Luyt,et al.  Fluorine and rhenium substituted ghrelin analogues as potential imaging probes for the growth hormone secretagogue receptor. , 2009, Journal of medicinal chemistry.

[4]  D. Fairlie,et al.  Metal clips that induce unstructured pentapeptides to be alpha-helical in water. , 2009, Journal of the American Chemical Society.

[5]  R. Schibli,et al.  Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors. , 2008, Bioconjugate chemistry.

[6]  D. Fairlie,et al.  Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformation. , 2008, Inorganic chemistry.

[7]  R. Schibli,et al.  "Click-to-chelate": in vitro and in vivo comparison of a 99mTc(CO)3-labeled N(tau)-histidine folate derivative with its isostructural, clicked 1,2,3-triazole analogue. , 2008, Bioconjugate chemistry.

[8]  L. Marzilli,et al.  fac-[Re(CO)(3)L](+) complexes with N-CH(2)-CH(2)-X-CH(2)-CH(2)-N tridentate ligands. synthetic, X-ray crystallographic, and NMR spectroscopic investigations. , 2007, Inorganic chemistry.

[9]  W. Trogler,et al.  Manganese(I) and Rhenium(I) Pentacarbonyl(Trifluoromethanesulfonato) Complexes , 2007 .

[10]  R. Schibli,et al.  "Click to chelate": synthesis and installation of metal chelates into biomolecules in a single step. , 2006, Journal of the American Chemical Society.

[11]  D. Tourwé,et al.  Maillard Glycation of Peptides Containing the (NαHis)Ac Chelator for 99mTc(CO)3 Labeling , 2006, International Journal of Peptide Research and Therapeutics.

[12]  Veronique Maes,et al.  Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties. , 2006, Journal of medicinal chemistry.

[13]  Kimberly N. White,et al.  Facile synthesis of highly functionalized N-methyl amino acid esters without side-chain protection. , 2005, Organic letters.

[14]  L. Marzilli,et al.  Complexes having the fac-[M(CO)3]+ core (M=Tc, Re) useful in radiopharmaceuticals: X-ray and NMR structural characterization and density functional calculations of species containing two sp3 N donors and one sp3 O donor. , 2004, Inorganic chemistry.

[15]  B. Spingler,et al.  Conjugation of a novel histidine derivative to biomolecules and labelling with [99mTc(OH2)3(CO)3]+. , 2004, Organic & biomolecular chemistry.

[16]  B. Spingler,et al.  N(epsilon) functionalization of metal and organic protected L-histidine for a highly efficient, direct labeling of biomolecules with [Tc(OH2)3(CO)3]+. , 2003, Chemistry.

[17]  R. Schibli,et al.  Current use and future potential of organometallic radiopharmaceuticals , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  R. Schibli,et al.  Synthesis and properties of boranocarbonate: a convenient in situ CO source for the aqueous preparation of [(99m)Tc(OH(2))3(CO)3]+. , 2001, Journal of the American Chemical Society.

[19]  R. Schibli,et al.  Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. , 2000, Bioconjugate chemistry.

[20]  L. Luyt,et al.  Lysine conjugates for the labelling of peptides with technetium-99m and rhenium , 2000 .

[21]  L. Luyt,et al.  Single isomer technetium-99m tamoxifen conjugates. , 2000, Bioconjugate chemistry.

[22]  R. Schibli,et al.  Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  L. Luyt,et al.  An N2S2 bifunctional chelator for technetium-99m and rhenium: complexation, conjugation, and epimerization to a single isomer. , 1999, Bioconjugate chemistry.

[24]  R. Schibli,et al.  Structural and (99)Tc NMR Investigations of Complexes with fac-[Tc(CO)(3)](+) Moieties and Macrocyclic Thioethers of Various Ring Sizes: Synthesis and X-ray Structure of the Complexes fac-[Tc(9-ane-S(3))(CO)(3)]Br, fac-[Tc(2)(tosylate)(2)(18-ane-S(6))(CO)(6)], and fac-[Tc(2)(20-ane-S(6)-OH)(CO)(6)][ , 1998, Inorganic chemistry.

[25]  R. Schibli,et al.  Application of technetium and rhenium carbonyl chemistry to nuclear medicine. Preparation of [NEt4]2[TcCl3(CO)3] from [NBu4][TcO4] and structure of [NEt4][Tc2(μ-Cl)3(CO)6]; structures of the model complexes [NEt4][Re2(μ-OEt)2(μ-OAc)(CO)6] and [ReBr({-CH2S(CH2)2Cl}2)(CO)3] , 1997 .

[26]  R. Schibli,et al.  Reactions with the technetium and rhenium carbonyl complexes (NEt4)2[MX3(CO)3]. Synthesis and structure of [Tc(CN-But)3(CO)3](NO3) and (NEt4)[Tc2(μ-SCH2CH2OH)3(CO)6] , 1996 .

[27]  J. Bading,et al.  Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. , 2004, Nuclear medicine and biology.

[28]  R. Schibli,et al.  Synthesis and structures of technetium(I) and rhenium(I) tricarbonyl complexes with bis(diphenylthiophosphoryl)amide, |M(CO)3[(Ph2PS)2N](CH3CN)| (M = Tc, Re) , 1998 .

[29]  R. Schibli,et al.  Potential of the "[M(CO)3]+" (M = Re, Tc) Moiety for the Labeling of Biomolecules , 1997 .

[30]  Alun G. Jones,et al.  Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations. , 1984, International journal of nuclear medicine and biology.